Polycythemia vera
Polycythemia vera (abbreviated as true erythrocythemia) is a clonal chronic myeloproliferative disease with predominantly erythrocytosis accompanied by leukocytosis and thrombocytosis. The total blood volume is absolutely increased and the blood is viscous. The clinical manifestations include red and purple skin, dizziness, headache, hypertension, hepatosplenomegaly, and severe patients may develop vascular and neurological complications such as bleeding and infarction.
-
Site of disease:
Bone marrow blood vessels -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Bleeding tendency epistaxis erythrocytosis diplopia erythrocytosis -
Concurrent disease:
Related Drugs
Xinnaoxin Tablets
Manufacturer:
Zhejiang Kangde Pharmaceutical Group Co., Ltd.
Harringtonine Injection
Indication: It is used to treat acute myeloid leukemia, and also has certain efficacy on myelodysplastic syndrome (MDS), polycythemia vera, and chronic myeloid leukemia.
Manufacturer:
Fuzhou FU Yao Pharmaceutical Co., Ltd.
Harringtonine Injection
Indication: It is used to treat acute myeloid leukemia, and also has certain efficacy on myelodysplastic syndrome (MDS), polycythemia vera, and chronic myeloid leukemia.
Manufacturer:
Fuzhou FU Yao Pharmaceutical Co., Ltd.
Harringtonine Injection
Indication: It is used to treat acute myeloid leukemia, and also has certain efficacy on myelodysplastic syndrome (MDS), polycythemia vera, and chronic myeloid leukemia.
Manufacturer:
Yaopharma Co., Ltd.
Harringtonine Injection
Indication: It is used to treat acute myeloid leukemia, and also has certain efficacy on myelodysplastic syndrome (MDS), polycythemia vera, and chronic myeloid leukemia.
Manufacturer:
Yaopharma Co., Ltd.
Harringtonine Injection
Indication: It is used to treat acute myeloid leukemia, and also has certain efficacy on myelodysplastic syndrome (MDS), polycythemia vera, and chronic myeloid leukemia.
Manufacturer:
Shanxi Guorun Pharmaceutical Co., Ltd.
Homoharringtonine Injection
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Homoharringtonine Injection
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain therapeutic effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:
Chengdu Beite Denuo Pharmaceutical Co., Ltd.
Homoharringtonine Injection
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain therapeutic effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:
Yaopharma Co., Ltd.
Homoharringtonine
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain therapeutic effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Related Ingredients